These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31343348)
1. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met). Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348 [No Abstract] [Full Text] [Related]
2. TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients. Luigetti M; Conte A; Del Grande A; Bisogni G; Madia F; Lo Monaco M; Laurenti L; Obici L; Merlini G; Sabatelli M Neurol Sci; 2013 Jul; 34(7):1057-63. PubMed ID: 22592564 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation. Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341 [No Abstract] [Full Text] [Related]
4. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan. Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687 [TBL] [Abstract][Full Text] [Related]
5. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study. Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sakurai T; Shimohata T; Katsuno M; Sobue G J Neurol Sci; 2018 Nov; 394():99-106. PubMed ID: 30243104 [TBL] [Abstract][Full Text] [Related]
6. Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report. Cisneros-Barroso E; Losada-López I; González-Moreno J; Buades J; Ferrer-Nadal A; Ripoll-Vera T; Usón M; Figuerola A; Montalà JC; Descals C; Salva-Ramonell F; Torres-Rovira J; Gene-Heym A; Fernández-Burgos I; Soler T Amyloid; 2019; 26(sup1):59-60. PubMed ID: 31343326 [No Abstract] [Full Text] [Related]
7. Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis. Masuda T; Ueda M; Misumi Y; Nomura T; Inoue Y; Isoguchi A; Kanenawa K; Tasaki M; Yamashita T; Sonoda Y; Obayashi K; Ando Y Amyloid; 2019; 26(sup1):79-80. PubMed ID: 31343297 [No Abstract] [Full Text] [Related]
8. Misdiagnosis in late versus early onset hATTR amyloidosis patients: experience from a reference centre. Falcão de Campos C; Parreira S; Conceição I Amyloid; 2019; 26(sup1):37-38. PubMed ID: 31343293 [No Abstract] [Full Text] [Related]
9. A case report of osteoarthritis associated with hereditary transthyretin amyloidosis ATTRV30M. Anan I; Bång J; Lundgren HE; Wixner J; Westermark P Amyloid; 2019; 26(sup1):29-30. PubMed ID: 31343355 [No Abstract] [Full Text] [Related]
10. Early diagnostic tools in hereditary amyloidosis related to transthyretin (hATTR) V30M autonomic neuropathy. de Campos CF; Conceição I; Castro I Amyloid; 2019; 26(sup1):35-36. PubMed ID: 31343294 [No Abstract] [Full Text] [Related]
11. Cardiac involvement in a large cohort of patients with Val30Met transthyretin amyloidosis from Majorca focus. Ripoll-Vera T; Alvarez J; Buades J; Cisneros E; Gomez Y; Melia C; Ferrer A; Losada I; Gonzalez J; Uson M; Figuerola A Amyloid; 2019; 26(sup1):15-16. PubMed ID: 31343338 [No Abstract] [Full Text] [Related]
12. Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis. Koike H; Yasuda T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sobue G; Katsuno M Amyloid; 2018 Jun; 25(2):141-142. PubMed ID: 29855203 [No Abstract] [Full Text] [Related]
13. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser). Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724 [No Abstract] [Full Text] [Related]
14. A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation. Matsumoto S; Ueda M; Yamashita T; Amano T; Misumi Y; Tasaki M; Masuda T; Mizukami M; Furuya H; Ando Y Amyloid; 2017 Mar; 24(sup1):97-98. PubMed ID: 28434367 [No Abstract] [Full Text] [Related]
15. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674 [TBL] [Abstract][Full Text] [Related]
16. Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation. Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):13-14. PubMed ID: 31343285 [No Abstract] [Full Text] [Related]
17. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231 [TBL] [Abstract][Full Text] [Related]
19. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096 [TBL] [Abstract][Full Text] [Related]
20. Transthyretin-related hereditary amyloidosis in an Argentinian family with TTR Tyr114Cys mutation. Aguirre MA; Nucifora EM; Rugiero M; Sorroche P; Saez MS; Giunta DH; Posadas-Martinez ML; Boietti BR Amyloid; 2017 Mar; 24(sup1):102. PubMed ID: 28434328 [No Abstract] [Full Text] [Related] [Next] [New Search]